MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 10mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 5mg tablets (Astellas Pharma Ltd).

Stability Notes

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Trimethoprim 100mg tablets (Crescent Pharma Ltd).

Stability Notes

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Trimethoprim 200mg tablets (Accord Healthcare Ltd) and Trimethoprim 200mg tablets (Crescent Pharma Ltd).

Stability Notes

Store in airtight containers, protect from light. Contains a desiccant, which makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Ferrous gluconate 300mg tablets (Kent Pharma (UK) Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 4mg modified-release tablets (Pfizer Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 8mg modified-release tablets (Pfizer Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from generic co-codamol 8mg/500mg capsules.

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.